Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brooke Meade"'
Autor:
Kurt B. Angstman, Matthew R. Meunier, Sarah M. Jenkins, Jay-Sheree Allen, Brooke Meade, Kristi S. Borowski
Publikováno v:
European Journal for Person Centered Healthcare. 6:535
Background: Exercise during pregnancy has minimal risks and has been shown to benefit most women, including reduction in cesarean section rates, appropriate maternal and fetal weight gain managing gestational diabetes as well as preventing and treati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe1fa735e3c8e24b6c48b5e098669bc
https://doi.org/10.5750/ejpch.v6i4.1543
https://doi.org/10.5750/ejpch.v6i4.1543
Publikováno v:
Blood. 116:4185-4191
Patients with mantle cell lymphoma (MCL) typically respond to initial treatment but subsequently relapse. This pattern suggests that a population of MCL cells is both drug resistant and capable of clonogenic growth. The intracellular enzyme retinalde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f7a610b3acb553ff3d0e1a1c606941b
https://doi.org/10.1182/blood-2010-02-268375
https://doi.org/10.1182/blood-2010-02-268375
Autor:
Jeanne Kowalski, Milada S. Vala, Eunpi Cho, Erica D. Warlick, Gideon M. Blumenthal, Michelle A. Rudek, Richard J. Jones, Sharyn D. Baker, Brooke Meade, Steven D. Gore, Zhe Zhang, William Matsui, Anthony J. Murgo, B. Douglas Smith, Robert A. Brodsky, Judith E. Karp, Ming Zhao, Steven Piantadosi
Publikováno v:
Leukemia research, vol 35, iss 1
Smith, BD; Jones, RJ; Cho, E; Kowalski, J; Karp, JE; Gore, SD; et al.(2011). Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF. Leukemia Research, 35(1), 87-94. doi: 10.1016/j.leukres.2010.06.001. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0h3444x9
Smith, BD; Jones, RJ; Cho, E; Kowalski, J; Karp, JE; Gore, SD; et al.(2011). Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF. Leukemia Research, 35(1), 87-94. doi: 10.1016/j.leukres.2010.06.001. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0h3444x9
Purpose: Pharmacologic differentiating agents have had relatively limited clinical success outside of the use of ATRA in acute promyelocytic leukemia and DNA methyltransferase inhibitors in myelodysplastic syndromes. The differentiating effects of su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e49bcf87d285761bf6e876956ae467e
https://escholarship.org/uc/item/0h3444x9
https://escholarship.org/uc/item/0h3444x9
Studies of primate vocal communication systems have generally focused on vocalizations and the information they convey to conspecifics. But the vocalizations are not the only sources of information. Aspects of each species vocal behaviors are also li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e339f5eb1f325dd480b1d0df546ce0
https://europepmc.org/articles/PMC3787898/
https://europepmc.org/articles/PMC3787898/
Publikováno v:
Blood. 112:884-884
Patients with Mantle Cell Lymphoma (MCL) often respond to initial cytotoxic therapy, but invariably relapse. This clinical pattern suggests that standard therapies fail to eliminate a population of chemoresistant cells responsible for tumor regrowth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc1a9e5000ec8d37e210b5564de3b6b
https://doi.org/10.1182/blood.v112.11.884.884
https://doi.org/10.1182/blood.v112.11.884.884